The gut-brain axis plays a crucial role in overall health by regulating communication between the gastrointestinal and nervous systems. Our products target intestinal permeability to improve gut barrier function and reduce inflammation, promoting better brain health. Supported by the latest scientific research, we offer therapeutic solutions to optimize gut-brain communication and overall well-being. Our goal is to enhance health by addressing these critical imbalances.
SynchroAxis represents a significant advancement in the formulation and production of products for human health. This technology is based on the precise synchronization of circadian rhythms and the individual pathophysiological needs of each patient. By considering these factors, SynchroAxis optimizes the absorption and efficacy of active ingredients, providing unique treatments on the market that are more personalized and effective.
SynchroAxis represents a significant advancement in the formulation and production of products for human health. This technology is based on the precise synchronization of circadian rhythms and the individual pathophysiological needs of each patient. By considering these factors, SynchroAxis optimizes the absorption and efficacy of active ingredients, providing unique treatments on the market that are more personalized and effective.
Viholabs’ SynchroAxis technology not only focuses on creating high-quality products but also drives innovation in the healthcare field. The ability to tailor treatments to patients’ biological rhythms makes a crucial difference in their effectiveness. This translates to tangible improvements in health outcomes and a reduction in side effects, setting a new standard in medical care.
Viholabs focuses on high potential and opportunity markets, specifically those derived from the Gut-Brain Axis and related to our product lines, both in the market and in development. These markets represent areas with significant demand for innovative solutions, where Viholabs leverages its advanced technology and expertise to create a positive impact.
Viholabs develops effective and safe products, positioning itself as a market leader. Our strategy tackles the issue of overweight at its root. This solution arrives at the right time in a mature market worth tens of billions of dollars, where Viholabs has the capacity to take the lead in this enormous market.
Viholabs guarantees products that not only meet but exceed expectations for performance, safety, and efficacy. Our ability to develop high value-added products allows us to capture a significant share of these exclusive markets, standing out for our ability to deliver real and visible benefits. Viholabs also stands at the forefront of innovation in health technologies, offering advanced solutions for health diagnosis and monitoring.
We focus on developing products that improve gut function and immune balance, positively impacting the mental and emotional health of patients.
We address disorders such as:
These areas represent a high potential market due to the increasing incidence of these disorders and the demand for more effective and personalized treatments.
GLP-1 receptor agonists (such as Ozempic, Wegovy, etc.) are gaining popularity, but their availability for healthy individuals dealing with excess weight is limited, and they come with significant side effects.
The size of the global GLP-1 analogues market in terms of revenue was estimated to be worth $47.4 billion in 2024 and is poised to reach $471.1 billion by 2032, growing at a CAGR of 33.2% from 2024 to 2032.
This presents a massive market, affecting over 50% of the global population who struggle with overweight or the sensation of excess weight. The majority of these individuals are unable to legally access prescriptions for GLP-1 receptor agonists. This represents the largest segment of the market.
Viholabs, with its unique approach, emerges as the ultimate solution.
We develop effective and safe solutions that promote healthy longevity. Our products enhance vitality and quality of life in maturity, responding to the growing demand for treatments that address healthy aging.
We focus on inner beauty and inner health; our SynchroAxis technology enables us to develop products that stand out for their positive impact and support the enjoyment of greater longevity with more vitality.
These products not only address aesthetics but also improve overall health and well-being, helping our users maintain an active and fulfilling life.
This market has high potential due to the aging population and the desire to maintain an optimal quality of life in maturity.
Curious about us and our activities? Do not hesitate to send us a message, you are always welcome!
Bac de Roda, 73. 08005 Barcelona.
info@viholabs.com